Comprehensive quantitative magnetic resonance imaging in assessment of aortic valve disease
Comprehensive quantitative magnetic resonance imaging in assessment of aortic valve disease
批准号:
9324450
负责人:
Jing Liu
金额:
$36.73万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-15 至 2019-08-31
关键词:
4D MRIAgeAortaAortic Valve StenosisBiological MarkersBloodBlood flowBreathingCardiacCardiac healthCategoriesChronicCicatrixClinicalConventional SurgeryDataDeteriorationDevelopmentDimensionsDiseaseEvaluationFunctional disorderGadoliniumGoalsHealthcare SystemsHeartHeart failureHypertrophyImageImage AnalysisImageryImaging TechniquesInterventionKidneyLeftLeft Ventricular Ejection FractionLeft Ventricular HypertrophyLeft Ventricular RemodelingLeft ventricular structureLiteratureMagnetic Resonance ImagingMapsMeasurementMeasuresMethodsModelingMorphologyMovementMyocardialMyocardial dysfunctionMyocardial tissueNatureNew YorkOperative Surgical ProceduresOutcomePatient SelectionPatientsPhasePopulationProtocols documentationPublic HealthResolutionRight ventricular structureRiskScanningSeveritiesStagingSymptomsTechniquesTimeTissue imagingTissuesVentricularVentricular Functionaortic valveaortic valve disorderaortic valve replacementbasecardiovascular visualizationcoronary fibrosiseffective therapygadolinium oxideheart functionimaging Segmentationimprovedmeetingsmortalitynovelpatient populationpressuresuccess
中文摘要
项目总结/文摘
英文摘要
PROJECT SUMMARY/ABSTRACT
Patients with asymptomatic aortic valve stenosis (AS) patients have a high mortality risk. Treatment by
aortic valve replacement (AVR) is an effective therapy but requires timely identification of the appropriate
condition. The current approach for determining symptomatic status is highly subjective and often fails to
indicate intervention before irreversible cardiac damage occurs. Similarly, leaving at-risk asymptomatic patients
untreated may also result in their developing the adverse myocardial sequellae of AS. Evaluation of cardiac
ventricular morphology, global and regional cardiac function, aortic compliance, as well as myocardial tissue
composition would provide a comprehensive assessment of the heart health in patients with AS that could
track the remodeling of the LV as a result of chronic sustained aortic valve pressure overload.
In this project, we propose to develop three categories of magnetic resonance imaging (MRI) approaches
for comprehensively and quantitatively providing the desired evaluation on the heart health. They are: 1) 3D
CINE MRI for structural and functional evaluation; 2) 4D flow MRI for myocardial regional function and blood
flow assessment; and 3) 3D quantitative parametric mapping for tissue characterization, detecting myocardial
fibrosis. They are highly accelerated free-breathing whole heart and aorta imaging techniques, which are
well suitable for this fragile AS patient population who needs rapid acquisition, free breathing strategies, and no
requirement of contrast administration.
From the quantitative MRI measurements such as left ventricular ejection fraction (LVEF), LV hypertrophy,
LV diastolic and systolic dysfunction, myocardial fibrosis, and aortic stiffness and distensibility, their association
with severity of symptoms will be analyzed and best biomarkers for predicting symptomatic progression will be
identified.
This comprehensive quantitative MRI protocol for evaluation of myocardial tissue composition and
function, and aortic abnormalities in patients with severe aortic valve stenosis will more accurately assess the
effects of AS. More precisely, quantitative MR parameters may help predict development of symptoms and
progression of symptom severity in patients with critical aortic stenosis, and improve current patient selection
strategies for aortic valve replacement. Success of this project will have a strong impact on the health care
system given the clinical importance of severe aortic stenosis, and the inability of current methods to reliably
predict the development or progression of symptoms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Monitoring the three-dimensional motion of chromatin at single molecule resolution
-
批准号:10706571
-
项目类别:
-
资助金额:$38.95万
-
财政年份:2022
-
负责人:Jing Liu
-
依托单位:
Monitoring the three-dimensional motion of chromatin at single molecule resolution
-
批准号:10501770
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2022
-
负责人:Jing Liu
-
依托单位:
3D Multi-Contrast MRI with Automatic Brain Tissue and Lesion Segmentation
-
批准号:10062912
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2019
-
负责人:Jing Liu
-
依托单位:
4D MRI Development for Cardiovascular Imaging
-
批准号:8443127
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2012
-
负责人:Jing Liu
-
依托单位:
4D MRI Development for Cardiovascular Imaging
-
批准号:8550806
-
项目类别:
-
资助金额:$16.84万
-
财政年份:2012
-
负责人:Jing Liu
-
依托单位:
4D MRI Development for Cardiovascular Imaging
-
批准号:8726767
-
项目类别:
-
资助金额:$16.84万
-
财政年份:2012
-
负责人:Jing Liu
-
依托单位:
4D MRI Development for Cardiovascular Imaging
-
批准号:8919361
-
项目类别:
-
资助金额:$16.84万
-
财政年份:2012
-
负责人:Jing Liu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: